3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
2
130-nm albumin-bound paclitaxel
2
paricalcitol
1
mitazalimab
1
ivosidenib
1
Tissue Banks
1
Specimen Handling
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Leucovorin
1
Irinotecan
1
Hydroxychloroquine
1
Glucose
1
Genetic Testing
1
Fluorouracil
1
Fecal Microbiota Transplantation
1
Escitalopram
1
Contrast Media
1
Capecitabine
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Ductal Adenocarcinoma
×
mitazalimab
×
1 year
×
Clear all
NCT07199764
2026-03-06
IGNITE
University of Pennsylvania
Phase 2
Recruiting
100 enrolled